Sandu Pharmaceuticals Limited (BOM:524703)
51.54
-0.88 (-1.68%)
At close: Jun 9, 2025
Sandu Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Sandu Pharmaceuticals had annual revenue of 671.92M INR, down -0.13%. Sandu Pharmaceuticals had revenue of 140.69M in the quarter ending March 31, 2025, a decrease of -9.80%.
Revenue
671.92M
Revenue Growth
-0.13%
P/S Ratio
0.76
Revenue / Employee
2.37M
Employees
283
Market Cap
507.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 671.92M | -883.00K | -0.13% |
Mar 31, 2024 | 672.81M | 19.32M | 2.96% |
Mar 31, 2023 | 653.49M | -1.52M | -0.23% |
Mar 31, 2022 | 655.01M | 67.45M | 11.48% |
Mar 31, 2021 | 587.55M | 103.10M | 21.28% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Life Insurance Corporation of India | 8,901.58B |